InvestorsObserver
×
News Home

Can Pharvaris NV (PHVS) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, December 22, 2022 01:07 PM | InvestorsObserver Analysts

Mentioned in this article

Can Pharvaris NV (PHVS) Stock Rise to the Top of Healthcare Sector Thursday?

Pharvaris NV (PHVS) is near the top in its sector according to InvestorsObserver. PHVS gets an overall rating of 69. That means it scores higher than 69% of stocks. Pharvaris NV gets a 90 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 69
PHVS has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on PHVS!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 69 would rank higher than 69 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Pharvaris NV Stock Today?

Pharvaris NV (PHVS) stock has risen 4.97% while the S&P 500 is lower by -2.71% as of 12:57 PM on Thursday, Dec 22. PHVS has gained $0.45 from the previous closing price of $9.05 on volume of 289,174 shares. Over the past year the S&P 500 is down -19.66% while PHVS is lower by -40.44%. PHVS lost -$1.76 per share the over the last 12 months. Click Here to get the full Stock Report for Pharvaris NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App